Development and Evaluation of Peptide-Based [ 18 F]AlF-WT12 and [ 18 F]AlF-IPB-WT12 Radiotracers for Noninvasive PD-L1 Imaging in Tumor Models
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c01032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Chunwei Mo und 10 weiteren Autor:innen. Beteiligte Einrichtung: GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical U…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Fluorine Radioisotopes, Radiopharmaceuticals, Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Medical Research Foundation, President Foundation of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
PD-L1 in the immune checkpoint pathway is expressed on various tumor cells, and multiple PD-1/PD-L1 inhibitors have been approved for treating these malignancies. However, clinical studies indicate that only 20-30% of patients benefit from immunotherapy. To address this problem, two novel peptide-based radiotracers, [18F]AlF-WT12 and [18F]AlF-IPB-WT12, were developed within the present study. Both tracers were successfully prepared, with radiochemical yields of 15-25% and 25-35%, respectively (n > 5), and both exhibited high molar activities (17.97-30.11 GBq/μmol and 18.09-26.46 GBq/μmol, respectively). Their evaluation using in vivo PET imaging demonstrated significantly higher accumulation of both tracers in PD-L1-expressing 4T1-hPD-L1 and A549-hPD-L1 tumors compared to CHO control tumors. Notably, the [18F]AlF-IPB-WT12 exhibited superior tumor uptake and prolonged retention time relative to [18F]AlF-WT12. Additionally, good correlations were obtained between the PET imaging results and the results obtained from biodistribution studies and immunohistochemistry studies. Together, our findings demonstrate the promise of [18F]AlF-IPB-WT12 as a tracer for noninvasive tumor imaging in clinical settings, with potential to guide immunotherapy decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
- Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China.
- Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China.
- Liver Tumor Center, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
ORCID-Profile: Ganghua Tang, Penghui Sun
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Medical Research Foundation
- President Foundation of Nanfang Hospital, Southern Medical University
- Guangzhou Key Research and Development Program on Agriculture and Social Development Science
- Medical Products Administration of Guangdong Province
Zitieren
APA
Mo, C., Tan, J. E., Zhang, M., Chen, Z., Zhu, Y., Han, Y., Wang, M., Dong, Y., Xi, B., Tang, G., & Sun, P. (2025). Development and Evaluation of Peptide-Based [ 18 F]AlF-WT12 and [ 18 F]AlF-IPB-WT12 Radiotracers for Noninvasive PD-L1 Imaging in Tumor Models. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01032
Vancouver
Mo C, Tan JE, Zhang M, Chen Z, Zhu Y, Han Y, et al. Development and Evaluation of Peptide-Based [ 18 F]AlF-WT12 and [ 18 F]AlF-IPB-WT12 Radiotracers for Noninvasive PD-L1 Imaging in Tumor Models. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01032
BibTeX
@article{Mo2025,
author = {Mo, Chunwei and Tan, Jian-Er and Zhang, Meilian and Chen, Zihao and Zhu, Yun and Han, Yanjiang and Wang, Meng and Dong, Ye and Xi, Baomin and Tang, Ganghua and Sun, Penghui},
title = {Development and Evaluation of Peptide-Based [ 18 F]AlF-WT12 and [ 18 F]AlF-IPB-WT12 Radiotracers for Noninvasive PD-L1 Imaging in Tumor Models},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c01032}
}
EUVIMED